MAPT and Alzheimer disease: Relevant researchers have indicated that the characteristic pathological signs of Alzheimer’s Disease (including Aβ and pTau accumulation) can emerge in the retina of affected individuals, which provides unique insights into the preclinical progression of the disease, and retinal amyloid/tau pathological imaging is the frontier direction of AD biomarker research.